14 Jan

Net Tangible Asset Backing & Fund Update

NTA per unit Gross assets (millions) Distributions per unit (percentage of initial investment) One month performance 1,2 Annualised performance since inception (July 2016) 1,2 $2.09 $193.4 Last 12 months: 89.5 cents (56%) Since inception: 90.8 cents (57%) -1.1% 14.3% Fund update The estimated unaudited net tangible asset value (NTA) after tax as at 31 December 2021 was $2.09 1,3 per unit (30 November 2021 was $2.65 1 per unit). Net asset value movements for December were primarily a result of payment of a 53 cents per unit distribution (declared: 20 December 2021, payment date: 21 January 2022) and foreign exchange losses from the strengthening Australian dollar (which detracted approximately 1.9%). CD3 Fund performance 1 Month 3 Months 6 Months 1 Year 3 Years p.a. 5 Years p.a. Since inception p.a. 3 NTA return 1,2 -1.1% 4.4% 22.4% 69.2% 24.2% 15.2% 14.3% On an NTA/Internal Rate of Return (IRR) basis CD3 has achieved a return of 13.0% per annum since inception. ASX release date: 14 January 2022 Notes: Authorised for release by E&P Investments Limited (ACN 152 367 649, AFSL 410 433), the responsible entity of CD Private Equity Fund III (Fund or CD3). 1. Source: E&P Investments Limited – the historical performance is not a guarantee of the future performance of the Fund; 2. Total returns are inclusive of distributions. NTA return is based on post tax NTA; 3. Based on estimated unaudited net tangible asset value before tax at 31 December 2021 of $2.15 per unit (30 November 2021 was $2.74). Numbers may not add due to rounding. Monthly update – December 2021 CD Private Equity Fund III Level 15, 100 Paci?c Highway North Sydney NSW 2060 T 1300 454 801 F 1300 883 159 E info@cdfunds.com.au cdfunds.com.au ARSN 612 132 813 CD3 portfolio asset allocation LP commitments to underlying managers (US$117.5m) 20.3% 10.1% 17.1% 17.6% 26.4% 8.5% $7.5 $5.0 $7.5 $10.0 $5.0 $7.5 $7.5 $10.0 $5.0 $5.0 $10.0 $27.5 $10.0 Software & Technology Distribution Business Services Manufacturing Consumer & Retail Healthcare DFW Elephant Encore Incline PeakSpan Telescope Trive US Select Direct II Luminate Gemspring Bertram Growth Street NMS
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2022 Listcorp. ABN 60 166 140 307

Never miss news from Cordish Dixon Private Equity Fund III (ASX:CD3) when you join Listcorp.